Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell interactions.


Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
12 2023
Historique:
received: 19 04 2023
revised: 23 09 2023
accepted: 26 09 2023
medline: 27 11 2023
pubmed: 4 10 2023
entrez: 3 10 2023
Statut: ppublish

Résumé

Chimeric antigen receptor (CAR) T cell therapy has demonstrated remarkable success as an immunotherapy for hematological malignancies, and its potential for treating solid tumors is an active area of research. However, limited trafficking and mobility of T cells within the tumor microenvironment (TME) present challenges for CAR T cell therapy in solid tumors. To gain a better understanding of CAR T cell function in solid tumors, we subjected CD70-specific CAR T cells to a challenge by evaluating their immune trafficking and infiltration through a confined 3D microchannel network in a bio-conjugated liquid-like solid (LLS) medium. Our results demonstrated successful CAR T cell migration and anti-tumor activity against CD70-expressing glioblastoma and osteosarcoma tumors. Through comprehensive analysis of cytokines and chemokines, combined with in situ imaging, we elucidated that immune recruitment occurred via chemotaxis, and the effector-to-target ratio plays an important role in overall antitumor function. Furthermore, through single-cell collection and transcriptomic profiling, we identified differential gene expression among the immune subpopulations. Our findings provide valuable insights into the complex dynamics of CAR T cell function in solid tumors, informing future research and development in this promising cancer treatment approach. STATEMENT OF SIGNIFICANCE: The use of specialized immune cells named CAR T cells to combat cancers has demonstrated remarkable success against blood cancers. However, this success is not replicated in solid tumors, such as brain or bone cancers, mainly due to the physical barriers of these solid tumors. Currently, preclinical technologies do not allow for reliable evaluation of tumor-immune cell interactions. To better study these specialized CAR T cells, we have developed an innovative in vitro three-dimensional model that promises to dissect the interactions between tumors and CAR T cells at the single-cell level. Our findings provide valuable insights into the complex dynamics of CAR T cell function in solid tumors, informing future research and development in this promising cancer treatment approach.

Identifiants

pubmed: 37788737
pii: S1742-7061(23)00592-5
doi: 10.1016/j.actbio.2023.09.042
pii:
doi:

Substances chimiques

Receptors, Chimeric Antigen 0
Receptors, Antigen, T-Cell 0
Antigens, Neoplasm 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

466-479

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright © 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Duy T Nguyen (DT)

Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL 32610, United States.

Ruixuan Liu (R)

Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, University of Florida Brain Tumor Immunotherapy Program, Gainesville, FL 32611, United States.

Elizabeth Ogando-Rivas (E)

Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, University of Florida Brain Tumor Immunotherapy Program, Gainesville, FL 32611, United States.

Alfonso Pepe (A)

Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL 32610, United States.

Diego Pedro (D)

Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL 32610, United States.

Sadeem Qdaisat (S)

Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, University of Florida Brain Tumor Immunotherapy Program, Gainesville, FL 32611, United States; University of Florida Genetics Institute, Gainesville, FL 32610, United States.

Nhi Tran Yen Nguyen (NTY)

Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL 32610, United States.

Julia M Lavrador (JM)

Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL 32610, United States.

Griffin R Golde (GR)

Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL 32610, United States.

Ryan A Smolchek (RA)

Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL 32610, United States.

John Ligon (J)

Department of Pediatrics, Division of Pediatric Hematology Oncology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, United States.

Linchun Jin (L)

Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, University of Florida Brain Tumor Immunotherapy Program, Gainesville, FL 32611, United States.

Haipeng Tao (H)

Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, University of Florida Brain Tumor Immunotherapy Program, Gainesville, FL 32611, United States.

Alex Webber (A)

Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL 32610, United States.

Simon Phillpot (S)

Department of Materials Science and Engineering, University of Florida, Gainesville, FL 32610, United States.

Duane A Mitchell (DA)

Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, University of Florida Brain Tumor Immunotherapy Program, Gainesville, FL 32611, United States.

Elias J Sayour (EJ)

Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, University of Florida Brain Tumor Immunotherapy Program, Gainesville, FL 32611, United States.

Jianping Huang (J)

Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, University of Florida Brain Tumor Immunotherapy Program, Gainesville, FL 32611, United States. Electronic address: jianping.huang@neurosurgery.ufl.edu.

Paul Castillo (P)

Department of Pediatrics, Division of Pediatric Hematology Oncology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, United States. Electronic address: castillopa@ufl.edu.

W Gregory Sawyer (W)

Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL 32610, United States. Electronic address: wgsawyer@ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH